Daily sun protection is essential to maintain firmness and prevent future laxity
We know from leading scientific bodies, including the World Health Organization, that GLP-1 medications are powerful tools, but not standalone solutions
While this helps you feel full, it can also make the gut feel sluggish and affect gut bacteria, leading to bloating or discomfort
FlexTouch and KwikPen delivery systems minimize injection errors critical for GLP-1 therapies where dose escalation spanning 16 to 20 weeks requires milligram-level titration
Next-generation agents include CagriSema (semaglutide + cagrilintide, NDA filed December 2025, showing 22.7% weight loss), retatrutide (triple GIP/GLP-1/glucagon agonist, 28.7% weight loss in Phase 3), and orforglipron (oral non-peptide GLP-1, submitted to FDA)